VC-03

N/A

Report date: 2025/01/26 17:40:07

Base Information

Drug NameVC-03

Drug Alias Namehuman embryonic stem cell-derived pancreatic beta cell progenitors (ViaCyte)VC-03

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Pancreagenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy

Mechanisms of ActionStem cells stimulants

TargetsUpdating

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesViacyte Inc

China Registration ClassN/A

Develop Information

Active CompaniesViacyte Inc

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 1

Inactive IndicationsN/A

Other Information

ATC CodeN/A